Carnegie Mellon University

Company

Related News

AI Tools Target Early Cancer Detection and Clinical Trial Predictions

Artificial intelligence is advancing cancer care through early detection tools and improved clinical trial predictions. A Carnegie Mellon spinout is developing AI to identify high-risk patients, while predictive analytics are helping pharmaceutical companies prioritize promising compounds in oncology trials.

Related Clinical Trials

NCT ID Title Status Phase
NCT07375732

Transcranial Electrical Stimulation for Noninvasive Study of Menopausal/Perimenopausal Symptoms

NOT_YET_RECRUITING NA
NCT07350733

Cognitive Training for Student Sleep and Wellness

ACTIVE_NOT_RECRUITING NA
NCT06857123

Feasibility of Resting Intervals During Exercise Programs for Individuals With Knee Osteoarthritis

RECRUITING NA
NCT06822257

Drinking in Young Adult Duos (DYAD) Study

RECRUITING NA
NCT06459596

Pilot Brief Communal Coping Intervention for Adults With Type 2 Diabetes

COMPLETED NA
NCT06320808

Evaluating FDA's Proposed Patient Medication Information Handout

COMPLETED NA
NCT06315218

Examining the Health Effects of NPOWER365 Among Black Same Gender Loving Men

NOT_YET_RECRUITING NA
NCT06264258

Game-based Pediatric Diabetes Education

RECRUITING NA
NCT05925556

Pilot Brief Communal Coping Intervention for Adults With Type 1 Diabetes

COMPLETED NA
NCT05821608

Heads up Messages to Increase Call Pick-up Rates

UNKNOWN NA